HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells

[1]  M. Caskey,et al.  Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection , 2018, Current opinion in HIV and AIDS.

[2]  J. Dimitrov,et al.  Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity , 2018, Cell reports.

[3]  Y. Lévy,et al.  Early Antiretroviral Therapy Preserves Functional Follicular Helper T and HIV-Specific B Cells in the Gut Mucosa of HIV-1–Infected Individuals , 2018, The Journal of Immunology.

[4]  Hedda Wardemann,et al.  Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen , 2018, Nature Immunology.

[5]  B. Haynes,et al.  What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Breaking through Immunity's Glass Ceiling. , 2018, Cold Spring Harbor perspectives in biology.

[6]  M. Nussenzweig,et al.  Redemption for self-reactive antibodies , 2018, Science.

[7]  Benjamin T. Porebski,et al.  Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination , 2018, Science.

[8]  Nirmin Alsahafi,et al.  Impact of HIV-1 Envelope Conformation on ADCC Responses. , 2017, Trends in microbiology.

[9]  D. Antonopoulos,et al.  Natural polyreactive IgA antibodies coat the intestinal microbiota , 2017, Science.

[10]  S. Zolla-Pazner,et al.  Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo , 2017, Cell.

[11]  Scott B. Thompson,et al.  Breaching peripheral tolerance promotes the production of HIV-1–neutralizing antibodies , 2017, The Journal of experimental medicine.

[12]  M. Bemark,et al.  The regulation of gut mucosal IgA B-cell responses: recent developments , 2017, Mucosal Immunology.

[13]  H. Mouquet,et al.  Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity , 2017, Mucosal Immunology.

[14]  H. Mouquet,et al.  Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies , 2017, Journal of Virology.

[15]  H. Mouquet,et al.  Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity , 2016, Mucosal Immunology.

[16]  D. Frank,et al.  The gut microbiome and HIV-1 pathogenesis: a two-way street. , 2016, AIDS.

[17]  H. Liao,et al.  Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection , 2016, EBioMedicine.

[18]  J. Round,et al.  Do antibodies select a healthy microbiota? , 2016, Nature Reviews Immunology.

[19]  H. Liao,et al.  Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies , 2016, Journal of Virology.

[20]  H. Liao,et al.  Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies , 2016, Science Immunology.

[21]  L. Sollid,et al.  The human intestinal B-cell response , 2016, Mucosal Immunology.

[22]  H. Mouquet,et al.  Scarcity of autoreactive human blood IgA+ memory B cells , 2016, European journal of immunology.

[23]  C. Goodnow,et al.  Clonal redemption of autoantibodies by somatic hypermutation away from self-reactivity during human immunization , 2016, The Journal of experimental medicine.

[24]  H. Mouquet,et al.  Elimination of HIV-1-infected cells by broadly neutralizing antibodies , 2016, Nature Communications.

[25]  S. Tugizov.  Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease , 2016, Tissue barriers.

[26]  J. Routy,et al.  Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical Research , 2016, EBioMedicine.

[27]  Juliana K. Wambua,et al.  A LAIR-1 insertion generates broadly reactive antibodies against malaria variant antigens , 2015, Nature.

[28]  G. Pesole,et al.  BALB/c and C57BL/6 Mice Differ in Polyreactive IgA Abundance, which Impacts the Generation of Antigen-Specific IgA and Microbiota Diversity. , 2015, Immunity.

[29]  T. Kepler,et al.  Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies , 2015, Science.

[30]  D. Thieffry,et al.  Syncytial apoptosis signaling network induced by the HIV-1 envelope glycoprotein complex: an overview , 2015, Cell Death and Disease.

[31]  Jerome H. Kim,et al.  Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques , 2015, PLoS pathogens.

[32]  H. Liao,et al.  The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells , 2015, Mucosal Immunology.

[33]  H. Mouquet,et al.  Efficient generation of human IgA monoclonal antibodies. , 2015, Journal of immunological methods.

[34]  André Bleich,et al.  Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota , 2015, Nature Immunology.

[35]  H. Mouquet.  Antibody B cell responses in HIV-1 infection. , 2014, Trends in immunology.

[36]  B. Haynes,et al.  Polyreactivity and Autoreactivity among HIV-1 Antibodies , 2014, Journal of Virology.

[37]  K. Roskin,et al.  HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria. , 2014, Cell host & microbe.

[38]  T. Kepler,et al.  Restricted isotype, distinct variable gene usage, and high rate of gp120-specificity of HIV-1 Envelope-specific B cells in colostrum compared to those in blood of HIV-1-infected, lactating African women , 2014, Mucosal Immunology.

[39]  P. Gaulard,et al.  Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients , 2014, Mucosal Immunology.

[40]  X. Daniell,et al.  Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells. , 2014, Journal of immunological methods.

[41]  C. Goodnow,et al.  Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity , 2014, Proceedings of the National Academy of Sciences.

[42]  T. Kepler,et al.  An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1. , 2014, The Journal of clinical investigation.

[43]  Chaim A. Schramm,et al.  Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus , 2013, Nature.

[44]  T. Kepler,et al.  Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies , 2013, The Journal of experimental medicine.

[45]  W. Blattner,et al.  HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life , 2013, Mucosal Immunology.

[46]  Michael S. Seaman,et al.  Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies , 2012, Proceedings of the National Academy of Sciences.

[47]  J. Angel,et al.  Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity? , 2012, Mucosal Immunology.

[48]  J. Overbaugh,et al.  HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads , 2012, PLoS pathogens.

[49]  Y. Richard,et al.  Default in plasma and intestinal IgA responses during acute infection by simian immunodeficiency virus , 2012, Retrovirology.

[50]  H. Liao,et al.  Isolation of HIV-1-Neutralizing Mucosal Monoclonal Antibodies from Human Colostrum , 2012, PloS one.

[51]  M. Nussenzweig,et al.  Polyreactive antibodies in adaptive immune responses to viruses , 2012, Cellular and Molecular Life Sciences.

[52]  H. Ding,et al.  Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages , 2011, Journal of Virology.

[53]  T. Kepler,et al.  Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated , 2011, The Journal of experimental medicine.

[54]  Ron Diskin,et al.  Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding , 2011, Science.

[55]  M. Nussenzweig,et al.  Memory B Cell Antibodies to HIV-1 gp140 Cloned from Individuals Infected with Clade A and B Viruses , 2011, PloS one.

[56]  B. Haynes,et al.  HIV-Specific Functional Antibody Responses in Breast Milk Mirror Those in Plasma and Are Primarily Mediated by IgG Antibodies , 2011, Journal of Virology.

[57]  H. Wardemann,et al.  The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. , 2011, The Journal of clinical investigation.

[58]  R. Furler,et al.  Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response , 2010, Immunologic research.

[59]  O. Schwartz,et al.  Tetherin Restricts Productive HIV-1 Cell-to-Cell Transmission , 2010, PLoS pathogens.

[60]  C. Broder,et al.  Anti-gp41 Antibodies Cloned from HIV-Infected Patients with Broadly Neutralizing Serologic Activity , 2010, Journal of Virology.

[61]  H. Liao,et al.  Role of HIV membrane in neutralization by two broadly neutralizing antibodies , 2009, Proceedings of the National Academy of Sciences.

[62]  L. Lopalco,et al.  HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection: an IgA gene and functional analysis , 2009, Mucosal Immunology.

[63]  Jörn E. Schmitz,et al.  Polyclonal B Cell Differentiation and Loss of Gastrointestinal Tract Germinal Centers in the Earliest Stages of HIV-1 Infection , 2009, PLoS medicine.

[64]  Richard T. Wyatt,et al.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals , 2009, Nature.

[65]  John Sidney,et al.  Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection , 2007, Nature Medicine.

[66]  J. Leblond,et al.  A Truncated Alternative Spliced Isoform of Human Desmoglein 1 Contains a Specific T Cell Epitope Binding to the Pemphigus Foliaceus-Associated HLA Class II DRβ1*0102 Molecule1 , 2006, The Journal of Immunology.

[67]  Conrad C. Huang,et al.  Tools for integrated sequence-structure analysis with UCSF Chimera , 2006, BMC Bioinformatics.

[68]  Xiping Wei,et al.  Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.

[69]  Christine Hogan,et al.  Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[70]  M. Nussenzweig,et al.  Surrogate Light Chain Expressing Human Peripheral B Cells Produce Self-reactive Antibodies , 2004, The Journal of experimental medicine.

[71]  M. Nussenzweig,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.

[72]  P. Earl,et al.  Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein , 1997, Journal of virology.

[73]  R. Williams,et al.  Autoreactivity in HIV-1 infection: the role of molecular mimicry. , 1995, Clinical immunology and immunopathology.

[74]  A. Trkola,et al.  Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. , 1994, AIDS research and human retroviruses.

[75]  S. Zolla-Pazner,et al.  Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies , 1991, Journal of virology.

[76]  R. L. Bjork.  HIV-1: seven facets of functional molecular mimicry. , 1991, Immunology letters.

[77]  S. Zolla-Pazner,et al.  Generation of human monoclonal antibodies to human immunodeficiency virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[78]  J. Brenchley,et al.  Microbial translocation, immune activation, and HIV disease. , 2013, Trends in microbiology.

[79]  Michel C Nussenzweig,et al.  Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. , 2008, Journal of immunological methods.